PDT articles ↓

 

photodynamic therapy for rhinophyma

Rosacea News was interested in a recent paper about Photodynamic Therapy and Rhinophyma. It has been mentioned online and at a glance looks very interesting. The trouble with quoting just the title is that you have no idea what the article deals with. Look closely, it is only 2 pages.

Pubmed lists this paper, but it requires a bit more digging to find any more information.

Photodynamic therapy for rhinophyma, J Dermatol. 2004 Sep;31(9):771-2.

It turns out that this paper is a Letter to the Editor, so is unlikely to be as promising as hoped. `J Dermatol’ is The Journal of Dermatology from the Japanese Dermatological Association. The journal lists

key words: topical application; Aminolevulinic Acid, ALA; edema reduction, Photosensitizing Agents, rhinophyma

http://www.dermatol.or.jp/Journal/JD/2004/031090771.html

Reprint requests to:
Noriko Amari, M.D.,
Department of Dermatology,
Teikyo University Mizonokuchi Hospital,
3-8-3 Mizonokuchi, Takatsu,
Kawasaki 213-8507,
Japan.

See also from 2002. Photodynamic Therapy for the Dermatologist

Related Articles

Photodynamic Therapy and ALA (ALA-PDT)

From Skin & Aging, Volume 13, Issue 3, March 2005, Pages: 42 - 51

The Ever-Increasing Role of ALA-PDT, Part 2

The topical application of 5-amino-levulinic acid (ALA) and exposure to a variety of lasers and light sources and photodynamic therapy (PDT), has become a very popular dermatologic procedure for a variety of clinical concerns affecting our patients. Presently, 20% 5-aminolevulinic acid (Levulan) is the only FDA-approved formulation.ALA-PDT is fast becoming a standard treatment for photorejuvenation with and without actinic keratoses (AKs), acne vulgaris, rosacea, sebaceous gland hyperplasia and hidradenitis suppurativa.

See also

Related Articles